Irinotecan Hydrochloride Injection, USP is available as a sterile, pale yellow, clear, aqueous solution in a vial packaged within a carton in the following packaging configurations:
Store at 20° to 25°C (68° to 77°F). See USP Controlled Room Temperature (excursions permitted to 15° to 30°C (59° to 86°F)). Protect from light. It is recommended that the vial should remain in the carton until the time of use. Protect from freezing. Store Upright.
Inspect the vial for damage and visible signs of leaks before removing from the carton. If damaged, incinerate the unopened package.
Irinotecan Hydrochloride Injection, USP is a hazardous drug. Follow special handling and disposal procedures.1
Additional Resources
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine or vaccine.
Speak with a Pfizer Medical Information Professional regarding your Pfizer medicine or vaccine inquiry.
Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for a Pfizer medicine or a vaccine.
The submission will be reviewed during our standard business hours.
To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this medication, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website to report an adverse event related to a Pfizer medication, please call (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or by calling (800) 332-1088.